INDV
Indivior Pharmaceuticals, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+29/100
Last price
36.38
▲ 0.39 (1.08%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
35.77
Prev close
35.99
Day high
36.15
Day low
35.03
Volume
2.39M
Market cap
$4.24B
P/E (TTM)
12.87
52W range
22.78 – 42.81
Day trading desk
Gap from prior close
-0.61%
Prior close 35.99
VWAP
35.75
+1.78% from price
Relative volume
1.16×
Normal
Session range
10.24%
33.00 – 36.38
Position in range
100%
Near session high
ATR (14D)
0.99
2.71% of price
Prior day high
36.26
PDH
Prior day low
35.73
PDL
Bid / ask spread
—
Quote not published
Session volume
2.39M
Avg 2.06M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.89%
-3.8%
1M
+2.75%
+1.6%
3M
-12.20%
-16.7%
6M
+17.82%
-0.4%
YTD
+0.06%
-14.2%
1Y
+54.94%
+38.5%
3Y
+55.61%
-26.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on INDV open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+1.25M
Net buying
Buy transactions
10
1.32M shares
Sell transactions
3
73.17K shares
Net transactions
+13
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
2.13M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 27, 26 | ANDERSON WOODROW D Officer |
BUY | 1.50K | $53.53K | Direct |
| Aug 5, 26 | ANDERSON WOODROW D Officer |
BUY | 1.50K | $54.42K | Direct |
| Jul 10, 26 | HEIDBREDER CHRISTIAN Officer |
SELL | 18.59K | $764.63K | Direct |
| Jun 22, 26 | CIAFFONI JOSEPH J Chief Executive Officer |
— | 1.27M | — | Direct |
| Jun 11, 26 | HEIDBREDER CHRISTIAN Officer |
SELL | 18.59K | $707.38K | Direct |
| Jun 8, 26 | PREBLICK RYAN Chief Financial Officer |
SELL | 36.00K | $1.36M | Direct |
| May 13, 26 | NINIVAGGI DANIEL A Director |
STOCK | 6.52K | $0 | Direct |
| May 13, 26 | KINGSLEY STUART A Director |
STOCK | 6.52K | $0 | Direct |
| May 13, 26 | STEJBACH MARK Director |
STOCK | 6.52K | $0 | Direct |
| May 13, 26 | THOMPSON JULIET Director |
STOCK | 6.52K | $0 | Direct |
| May 13, 26 | WHEADON DAVID E. Director |
STOCK | 10.43K | $0 | Direct |
| May 13, 26 | RYAN BARBARA Director |
STOCK | 6.52K | $0 | Direct |
| May 13, 26 | HUMPHREYS KEITH Director |
STOCK | 6.52K | $0 | Direct |
| Mar 13, 26 | RYAN BARBARA Director |
BUY | 8 | $249 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANDERSON WOODROW D |
Officer | 27.64K | Purchase |
BARRY PATRICK A |
Officer | 31.38K | Stock Award(Grant) |
BURRIS JEFFREY W |
Officer | 71.52K | Conversion of Exercise of derivative security |
CIAFFONI JOSEPH J |
Chief Executive Officer | 790.33K | Conversion of Exercise of derivative security |
HEIDBREDER CHRISTIAN |
Officer | 209.34K | Sale |
NINIVAGGI DANIEL A |
Director | 27.16K | Stock Award(Grant) |
PREBLICK RYAN |
Chief Financial Officer | 284.75K | Sale |
STEJBACH MARK |
Director | 27.09K | Stock Award(Grant) |
THOMPSON JULIET |
Director | 18.75K | Stock Award(Grant) |
WHEADON DAVID E. |
Director | 30.78K | Stock Award(Grant) |
Fundamentals
Market cap$4.24B
Enterprise value$4.52B
Revenue (TTM)$1.33B
Gross profit$1.14B
EBITDA$576.00M
Net income$356.00M
EPS (TTM)$2.79
Free cash flow$86.50M
Total cash$222.00M
Total debt$509.00M
Book value / share$-1.76
Shares outstanding118.03M
Float109.46M
Short % of float11.25%
Dividend yield0.00%
Beta (5Y)1.18
Valuation & profitability ratios
Trailing P/E12.87
Forward P/E7.35
PEG ratio—
Price / sales—
Price / book—
EV / revenue3.40
EV / EBITDA7.85
Gross margin85.72%
Operating margin46.94%
Profit margin26.75%
Return on equity—
Return on assets26.40%
Debt / equity—
Current ratio0.84
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.24B | $1.19B | $1.09B | $901.00M | +4.3% |
| Operating revenue | $1.24B | $1.19B | $1.09B | $901.00M | +4.3% |
| Cost of revenue | $246.00M | $231.00M | $174.00M | $151.00M | +6.5% |
| Gross profit | $993.00M | $957.00M | $919.00M | $750.00M | +3.8% |
| Research & development | $97.00M | $107.00M | $116.00M | $74.00M | -9.3% |
| Selling, general & admin | $634.00M | $612.00M | $565.00M | $469.00M | +3.6% |
| Total operating expense | $728.00M | $723.00M | $672.00M | $535.00M | +0.7% |
| Operating income | $265.00M | $234.00M | $247.00M | $215.00M | +13.2% |
| Net interest income | -$23.00M | -$18.00M | $8.00M | -$8.00M | -27.8% |
| Pre-tax income | $239.00M | $20.00M | -$145.00M | -$89.00M | +1,095.0% |
| Tax provision | $29.00M | $13.00M | -$19.00M | -$44.00M | +123.1% |
| Net income | $210.00M | $7.00M | -$126.00M | -$44.00M | +2,900.0% |
| Net income to common | $210.00M | $7.00M | -$126.00M | -$44.00M | +2,900.0% |
| Basic EPS | 1.68 | -0.36 | 0.01 | -0.38 | +566.7% |
| Diluted EPS | 1.64 | -0.36 | 0.01 | -0.38 | +555.6% |
| EBIT | $284.00M | $61.00M | -$110.00M | -$62.00M | +365.6% |
| EBITDA | $304.00M | $89.00M | -$95.00M | -$46.00M | +241.6% |
| Basic shares | 125.00M | 132.31M | 137.31M | 139.01M | -5.5% |
| Diluted shares | 128.05M | 132.31M | 141.80M | 145.62M | -3.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $195.00M | $319.00M | $316.00M | $774.00M | -38.9% |
| Cash & short-term investments | $195.00M | $320.00M | $410.00M | $893.00M | -39.1% |
| Accounts receivable | $253.00M | $254.00M | $254.00M | $220.00M | -0.4% |
| Inventory | $155.00M | $178.00M | $135.00M | $114.00M | -12.9% |
| Total current assets | $652.00M | $827.00M | $1.27B | $1.26B | -21.2% |
| Property, plant & equipment | $170.00M | $139.00M | $124.00M | $85.00M | +22.3% |
| Goodwill & intangibles | $2.00M | $7.00M | $13.00M | $70.00M | -71.4% |
| Total assets | $1.20B | $1.32B | $1.76B | $1.77B | -8.7% |
| Total current liabilities | $914.00M | $924.00M | $1.29B | $1.02B | -1.1% |
| Current debt | $29.00M | $18.00M | $3.00M | $3.00M | +61.1% |
| Long-term debt | $290.00M | $315.00M | $237.00M | $237.00M | -7.9% |
| Total debt | $351.00M | $375.00M | $283.00M | $277.00M | -6.4% |
| Total liabilities | $1.30B | $1.65B | $1.95B | $1.72B | -21.4% |
| Retained earnings | -$243.00M | -$443.00M | -$295.00M | $1.30B | +45.1% |
| Shareholder equity | -$99.00M | -$337.00M | -$192.00M | $51.00M | +70.6% |
| Working capital | -$262.00M | -$97.00M | -$24.00M | $240.00M | -170.1% |
| Net tangible assets | -$101.00M | -$344.00M | -$205.00M | -$19.00M | +70.6% |
| Shares issued | 125.02M | 124.90M | 136.53M | 136.48M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $210.00M | $7.00M | -$126.00M | -$44.00M | +2,900.0% |
| Depreciation & amortisation | $20.00M | $28.00M | $15.00M | $16.00M | -28.6% |
| Stock-based compensation | $26.00M | $24.00M | $21.00M | $16.00M | +8.3% |
| Change in working capital | -$257.00M | -$46.00M | -$297.00M | $118.00M | -458.7% |
| Operating cash flow | -$27.00M | $36.00M | -$300.00M | -$4.00M | -175.0% |
| Capital expenditure | -$67.00M | -$31.00M | -$53.00M | -$5.00M | -116.1% |
| Investing cash flow | -$66.00M | $69.00M | -$95.00M | -$222.00M | -195.7% |
| Share buybacks | -$11.00M | -$173.00M | -$33.00M | -$90.00M | +93.6% |
| Financing cash flow | -$30.00M | -$102.00M | -$64.00M | -$101.00M | +70.6% |
| Free cash flow | -$94.00M | $5.00M | -$353.00M | -$9.00M | -1,980.0% |
| End cash position | $195.00M | $319.00M | $316.00M | $774.00M | -38.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $343.00M | $317.00M | $358.00M | $314.00M | $302.00M | — | +8.2% |
| Operating revenue | $343.00M | $317.00M | $358.00M | $314.00M | $302.00M | — | +8.2% |
| Cost of revenue | $50.00M | $40.00M | $67.00M | $83.00M | $52.00M | — | +25.0% |
| Gross profit | $293.00M | $277.00M | $291.00M | $231.00M | $250.00M | — | +5.8% |
| Research & development | $12.00M | $16.00M | $21.00M | $33.00M | $21.00M | — | -25.0% |
| Selling, general & admin | $122.00M | $124.00M | $189.00M | $155.00M | $158.00M | — | -1.6% |
| Total operating expense | $134.00M | $140.00M | $208.00M | $187.00M | $179.00M | — | -4.3% |
| Operating income | $159.00M | $137.00M | $83.00M | $44.00M | $71.00M | — | +16.1% |
| Net interest income | $1.00M | -$4.00M | $0 | -$6.00M | -$9.00M | — | +125.0% |
| Pre-tax income | $160.00M | $115.00M | $81.00M | $37.00M | $62.00M | — | +39.1% |
| Tax provision | $38.00M | $26.00M | -$21.00M | -$5.00M | $44.00M | — | +46.2% |
| Net income | $122.00M | $89.00M | $102.00M | $42.00M | $18.00M | — | +37.1% |
| Net income to common | $122.00M | $89.00M | $102.00M | $42.00M | $18.00M | — | +37.1% |
| Basic EPS | 1.02 | 0.71 | 0.82 | 0.34 | 0.15 | — | +43.7% |
| Diluted EPS | 0.98 | 0.69 | 0.79 | 0.33 | — | 0.38 | +42.0% |
| EBIT | $162.00M | $122.00M | $87.00M | $49.00M | $77.00M | — | +32.8% |
| EBITDA | $165.00M | $126.00M | $92.00M | $54.00M | $82.00M | — | +31.0% |
| Basic shares | 119.00M | 125.35M | 124.39M | 123.53M | 120.00M | — | -5.1% |
| Diluted shares | 124.00M | 128.99M | 129.11M | 127.27M | 128.57M | — | -3.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $222.00M | $175.00M | $195.00M | $445.00M | $510.00M | — | +26.9% |
| Cash & short-term investments | $222.00M | $175.00M | $195.00M | $445.00M | $510.00M | — | +26.9% |
| Accounts receivable | $271.00M | $273.00M | $253.00M | $259.00M | $240.00M | — | -0.7% |
| Inventory | $151.00M | $152.00M | $155.00M | $157.00M | $149.00M | — | -0.7% |
| Total current assets | $725.00M | $667.00M | $652.00M | $922.00M | $951.00M | — | +8.7% |
| Property, plant & equipment | $182.00M | $179.00M | $170.00M | $154.00M | $152.00M | — | +1.7% |
| Goodwill & intangibles | $2.00M | $2.00M | $2.00M | $2.00M | $7.00M | — | 0.0% |
| Total assets | $1.23B | $1.20B | $1.20B | $1.42B | $1.45B | — | +3.0% |
| Total current liabilities | $868.00M | $779.00M | $914.00M | $965.00M | $1.06B | — | +11.4% |
| Current debt | — | — | $29.00M | $18.00M | $18.00M | $18.00M | — |
| Long-term debt | $487.00M | $486.00M | $290.00M | $304.00M | $308.00M | — | +0.2% |
| Total debt | $509.00M | $509.00M | $351.00M | $356.00M | $366.00M | — | 0.0% |
| Total liabilities | $1.44B | $1.34B | $1.30B | $1.62B | $1.71B | — | +7.4% |
| Retained earnings | -$334.00M | -$280.00M | -$243.00M | -$346.00M | -$388.00M | — | -19.3% |
| Shareholder equity | -$207.00M | -$144.00M | -$99.00M | -$207.00M | -$258.00M | — | -43.8% |
| Working capital | -$143.00M | -$112.00M | -$262.00M | -$43.00M | -$105.00M | — | -27.7% |
| Net tangible assets | -$209.00M | -$146.00M | -$101.00M | -$209.00M | -$265.00M | — | -43.2% |
| Shares issued | 118.00M | 122.00M | 125.02M | 124.77M | 124.77M | — | -3.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $122.00M | $89.00M | $102.00M | $43.00M | $18.00M | +37.1% |
| Depreciation & amortisation | $3.00M | $4.00M | $5.00M | $5.00M | $5.00M | -25.0% |
| Stock-based compensation | $11.00M | $9.00M | $5.00M | $7.00M | $8.00M | +22.2% |
| Change in working capital | $64.00M | -$163.00M | -$299.00M | -$98.00M | $122.00M | +139.3% |
| Operating cash flow | $229.00M | -$9.00M | -$221.00M | -$39.00M | $158.00M | +2,644.4% |
| Capital expenditure | -$7.00M | -$20.00M | -$24.00M | -$20.00M | -$18.00M | +65.0% |
| Investing cash flow | -$8.00M | -$19.00M | -$24.00M | -$20.00M | -$17.00M | +57.9% |
| Share buybacks | -$176.00M | -$126.00M | $0 | $0 | $0 | -39.7% |
| Financing cash flow | -$173.00M | $7.00M | -$5.00M | -$3.00M | -$5.00M | -2,571.4% |
| Free cash flow | $222.00M | -$29.00M | -$245.00M | -$59.00M | $140.00M | +865.5% |
| End cash position | $222.00M | $175.00M | $195.00M | $445.00M | $510.00M | +26.9% |
Options analytics
Put / call volume
7.95
Put-heavy session
Put / call open interest
0.88
Positioning, not flow
Max pain
39.00
+8.6% from spot
ATM implied vol
65.3%
Nearest strike to spot
Skew (10% OTM)
+44.7%
Puts bid over calls
Call volume
42
Contracts, this expiry
Put volume
334
Contracts, this expiry
Heaviest call OI
39.00
301 contracts
Heaviest put OI
39.00
300 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.92 | 1.15 | +24.8% |
| Mar 2026 | 0.66 | 0.96 | +45.5% |
| Dec 2025 | 0.67 | 0.82 | +21.7% |
| Sep 2025 | 0.41 | 0.72 | +74.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.12 | 2 | $329.35M | +4.9% |
| Next quarter | 1.21 | 2 | $337.90M | -5.6% |
| Current year | 4.41 | 3 | $1.33B | +7.5% |
| Next year | 4.88 | 3 | $1.40B | +5.1% |
Analyst targets & ownership
Mean target$49.00
High target$53.00
Low target$43.00
Implied upside34.69%
Analyst count4
ConsensusNONE
Strong buy / Buy1 / 3
Hold0
Sell / Strong sell0 / 0
Held by insiders1.80%
Held by institutions102.80%
Institutions holding457
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
36.00
+1.05% from price
SMA 20
35.46
+1.25% from price
SMA 50
36.65
-2.04% from price
SMA 100
37.75
-3.63% from price
SMA 200
35.74
+0.46% from price
EMA 12
35.81
+1.59% from price
EMA 26
35.89
+1.36% from price
EMA 50
36.43
-0.13% from price
RSI (14)
49.9
Neutral
MACD (12,26,9)
-0.08
Hist 0.14
ATR (14)
0.99
2.75% of price
Realised vol 30D
22.1%
Annualised
Bollinger upper
36.98
20, 2σ
Bollinger lower
33.93
20, 2σ
50 / 200 cross
Golden
36.65 vs 35.74
Trend bias
Above 200
+0.46%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.45
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
22.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-21.4%
Peak to trough
Max drawdown 5Y
-85.5%
Peak to trough
ATR 14
0.99
2.75% of price
Beta (reported)
1.18
5Y monthly, from filing
Short interest
Shares short
11.17M
Prior 10.45M
Change vs prior
+6.9%
Shorts adding
% of float
11.25%
Elevated
% of shares out
9.47%
Against total outstanding
Days to cover
5.6
Crowded exit
Float
109.46M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 5, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jun 18, 26 | Barclays | INITIATED | — | Overweight |
| Jan 12, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Oct 31, 25 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Oct 30, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 27, 25 | Craig-Hallum | MAINTAINED | Buy | Buy |
| Aug 6, 25 | HC Wainwright & Co. | INITIATED | — | Buy |
| Jun 30, 25 | Craig-Hallum | MAINTAINED | Buy | Buy |
| Mar 6, 25 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Oct 25, 24 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Oct 11, 24 | Craig-Hallum | MAINTAINED | Buy | Buy |
| Oct 11, 24 | Piper Sandler | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend dateOct 30, 2026
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-06
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425 · 2026-09-17
Corporate Changes & Voting Matters
8-K · 2026-09-15
Offering Registrations
S-4/A · 2026-09-09
Offering Registrations
S-4 · 2026-08-28
Corporate Changes & Voting Matters
8-K · 2026-08-03
Corporate Changes & Voting Matters
8-K · 2026-05-15
Corporate Changes & Voting Matters
8-K · 2026-05-04
Headlines
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
GlobeNewswire · 20d ago
5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
Zacks · 23d ago
Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound?
Zacks · 34d ago
Indivior Pharmaceuticals Inc. (INDV) Loses 12.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks · 37d ago
3 Reasons Why Growth Investors Shouldn't Overlook Indivior Pharmaceuticals Inc. (INDV)
Zacks · 40d ago
Indivior Pharmaceuticals (INDV) Could Be 30% Undervalued On Its Cost Reset Plan
Simply Wall St. · 46d ago
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
Zacks · 46d ago
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
Zacks · 46d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.